JP2021535904A5 - - Google Patents
Info
- Publication number
- JP2021535904A5 JP2021535904A5 JP2021507445A JP2021507445A JP2021535904A5 JP 2021535904 A5 JP2021535904 A5 JP 2021535904A5 JP 2021507445 A JP2021507445 A JP 2021507445A JP 2021507445 A JP2021507445 A JP 2021507445A JP 2021535904 A5 JP2021535904 A5 JP 2021535904A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- nhc
- heterocyclyl
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022109092A JP2022130716A (ja) | 2018-08-13 | 2022-07-06 | ＩＲＡＫ４阻害剤としてのピロロ［１，２－ｂ］ピリダジン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862718273P | 2018-08-13 | 2018-08-13 | |
| US62/718,273 | 2018-08-13 | ||
| PCT/US2019/046380 WO2020036979A1 (en) | 2018-08-13 | 2019-08-13 | Pyrrolo[1,2-b]pyridazine derivatives as irak4 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022109092A Division JP2022130716A (ja) | 2018-08-13 | 2022-07-06 | ＩＲＡＫ４阻害剤としてのピロロ［１，２－ｂ］ピリダジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535904A JP2021535904A (ja) | 2021-12-23 |
| JP2021535904A5 true JP2021535904A5 (cg-RX-API-DMAC7.html) | 2022-07-14 |
| JP7169429B2 JP7169429B2 (ja) | 2022-11-10 |
Family
ID=67777432
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507445A Active JP7169429B2 (ja) | 2018-08-13 | 2019-08-13 | ＩＲＡＫ４阻害剤としてのピロロ［１，２－ｂ］ピリダジン誘導体 |
| JP2022109092A Withdrawn JP2022130716A (ja) | 2018-08-13 | 2022-07-06 | ＩＲＡＫ４阻害剤としてのピロロ［１，２－ｂ］ピリダジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022109092A Withdrawn JP2022130716A (ja) | 2018-08-13 | 2022-07-06 | ＩＲＡＫ４阻害剤としてのピロロ［１，２－ｂ］ピリダジン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11572362B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3837012A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7169429B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102660255B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112566697B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019321424B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3105795C (cg-RX-API-DMAC7.html) |
| TW (1) | TWI797366B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020036979A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022007376A (es) | 2019-12-20 | 2022-09-02 | Tenaya Therapeutics Inc | Fluoroalqull-oxadiazoles y sus usos. |
| US20240252502A1 (en) | 2021-05-04 | 2024-08-01 | Tenaya Therapeutics, Inc. | Hdac6 inhibitors for treatment of metabolic disease and hfpef |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3126330T3 (en) | 2014-04-04 | 2019-04-23 | Pfizer | BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS |
| US9624246B2 (en) | 2015-02-06 | 2017-04-18 | Merck Patent Gmbh | Pyridazinone macrocycles as IRAK inhibitors and uses thereof |
| EP3313840B1 (en) | 2015-06-24 | 2019-07-24 | Bristol-Myers Squibb Company | Heteroaryl substituted aminopyridine compounds |
| ES2822956T3 (es) | 2015-06-24 | 2021-05-05 | Bristol Myers Squibb Co | Compuestos de aminopiridina sustituidos con heteroarilo |
| US10618903B2 (en) * | 2015-06-24 | 2020-04-14 | Bristol-Myers Squibb Company | Heteroaryl substituted aminopyridine compounds |
| TW202340194A (zh) * | 2017-02-16 | 2023-10-16 | 美商基利科學股份有限公司 | 吡咯并[1,2-b]嗒𠯤衍生物 |
-
2019
- 2019-08-13 TW TW108128802A patent/TWI797366B/zh active
- 2019-08-13 US US16/539,753 patent/US11572362B2/en active Active
- 2019-08-13 CA CA3105795A patent/CA3105795C/en active Active
- 2019-08-13 KR KR1020217007282A patent/KR102660255B1/ko active Active
- 2019-08-13 WO PCT/US2019/046380 patent/WO2020036979A1/en not_active Ceased
- 2019-08-13 JP JP2021507445A patent/JP7169429B2/ja active Active
- 2019-08-13 CN CN201980053454.6A patent/CN112566697B/zh active Active
- 2019-08-13 EP EP19759815.4A patent/EP3837012A1/en active Pending
- 2019-08-13 AU AU2019321424A patent/AU2019321424B2/en active Active
-
2022
- 2022-06-22 AU AU2022204399A patent/AU2022204399A1/en not_active Abandoned
- 2022-07-06 JP JP2022109092A patent/JP2022130716A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019264641A1 (en) | Substituted spirocyclic inhibitors of autotaxin | |
| JP7815127B2 (ja) | インターロイキン－１受容体関連キナーゼの二機能性分解剤およびその治療的使用 | |
| KR102050150B1 (ko) | 융합-고리 화합물, 약학 조성물 및 이들의 용도 | |
| JP7411631B2 (ja) | インターロイキン－１活性の阻害剤としてのスルホニル尿素化合物 | |
| JP7112488B2 (ja) | タンパク質キナーゼ阻害剤としての複素環化合物 | |
| JP2021534124A5 (cg-RX-API-DMAC7.html) | ||
| RU2012152354A (ru) | Производные пирролопиразина в качестве ингибиторов syk и jak | |
| JP2021535904A5 (cg-RX-API-DMAC7.html) | ||
| JP2024531273A5 (cg-RX-API-DMAC7.html) | ||
| AR069509A1 (es) | Pirido (3,2-e) pirazinas, su procedimiento de preparacion y uso como inhibidores de fosfodiesterasa 10 | |
| JP2009504764A5 (cg-RX-API-DMAC7.html) | ||
| KR20170102885A (ko) | 삼환성 스피로 화합물 | |
| JP2018534326A (ja) | Ｒｏｒ−ガンマのモジュレーター | |
| AR084425A1 (es) | Derivados heterociclicos de 8-azabiciclo[3.2.1]octan-8-ilo, composiciones farmaceuticas que los contienen, proceso para prepararlos e intermediarios y uso de los mismos para tratar patologias hepaticas tales como dislipemias e hipercolesterolemia entre otras | |
| AR077974A1 (es) | Compuestos de hexahidrooxazinopterina para uso como inhibidores de mtor | |
| JP2020007360A (ja) | オートタキシンの置換ｎ−（２−アミノ）−２−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにｌｐａ依存性またはｌｐａ媒介性疾患の処置における使用 | |
| AR075951A1 (es) | Dihidropiridin sulfonamidas y dihidropiridin sulfamidas como inhibidores de mek | |
| JP2014513690A (ja) | Ｃ型肝炎ウイルス阻害剤 | |
| JP2023554596A (ja) | 化合物、組成物及び方法 | |
| JP2012522766A5 (cg-RX-API-DMAC7.html) | ||
| JP2013525356A5 (cg-RX-API-DMAC7.html) | ||
| JP7178401B2 (ja) | コリンキナーゼ阻害剤としてのピラゾロキナゾリン誘導体 | |
| JP2025533508A (ja) | Ｎｌｒｐ３インフラマソームの阻害剤としてのインダゾール化合物及びピラゾロピリジン化合物 | |
| ES2608359T3 (es) | Compuestos de pirazolo[3,4-d]pirimidina sustituidos, su preparación y uso como ligandos de receptores sigma | |
| AU2023357827A1 (en) | Cyclopentane compound |